{"id":4528,"date":"2018-01-15T14:22:52","date_gmt":"2018-01-15T13:22:52","guid":{"rendered":"http:\/\/kreftgenomikk.w.uib.no\/?p=4528"},"modified":"2018-11-12T11:13:26","modified_gmt":"2018-11-12T10:13:26","slug":"nsg","status":"publish","type":"post","link":"https:\/\/kreftgenomikk.w.uib.no\/no\/nsg\/","title":{"rendered":"Hva er persontilpasset kreftbehandling?"},"content":{"rendered":"<p>[et_pb_section admin_label=&raquo;Seksjon&raquo; fullwidth=&raquo;on&raquo; specialty=&raquo;off&raquo;][et_pb_fullwidth_post_title admin_label=&raquo;Fullbreddes innleggstittel&raquo; title=&raquo;on&raquo; meta=&raquo;off&raquo; author=&raquo;on&raquo; date=&raquo;on&raquo; categories=&raquo;on&raquo; comments=&raquo;on&raquo; featured_image=&raquo;on&raquo; featured_placement=&raquo;background&raquo; parallax_effect=&raquo;off&raquo; parallax_method=&raquo;on&raquo; text_orientation=&raquo;right&raquo; text_color=&raquo;light&raquo; text_background=&raquo;on&raquo; text_bg_color=&raquo;rgba(21,150,137,0.9)&raquo; module_bg_color=&raquo;rgba(255,255,255,0)&raquo; title_font=&raquo;|on|||&raquo; title_font_size=&raquo;35px&raquo; title_all_caps=&raquo;off&raquo; use_border_color=&raquo;off&raquo; border_color=&raquo;#ffffff&raquo; border_style=&raquo;solid&raquo; module_id=&raquo;header-image-and-text&raquo;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_fullwidth_post_title][\/et_pb_section][et_pb_section admin_label=&raquo;Seksjon&raquo; fullwidth=&raquo;off&raquo; specialty=&raquo;off&raquo;][et_pb_row admin_label=&raquo;Rad&raquo;][et_pb_column type=&raquo;2_3&#8243;][et_pb_text admin_label=&raquo;Tekst&raquo; background_layout=&raquo;light&raquo; text_orientation=&raquo;left&raquo; use_border_color=&raquo;off&raquo; border_color=&raquo;#ffffff&raquo; border_style=&raquo;solid&raquo;]<\/p>\n<div id=\"omosscoverboks\" class=\"coverboks\">\n<h4 class=\"covertittel\"><strong><em>Ny \u00e6ra for kreftbehandling<\/em><\/strong><\/h4>\n<p>&nbsp;<\/p>\n<\/div>\n<p><strong>Persontilpasset medisin eller presisjonsmedisin tar sikte p\u00e5 \u00e5 utvikle mer presise og detaljerte diagnostiske metoder og bruke dem til \u00e5 finne behandling som er bedre tilpasset hver enkelt pasient og dennes sykdom. Det er den raske utviklingen av analysen av det genetiske materialet og den sterkt \u00f8kende biologiske forst\u00e5elsen av kreftsykdommene som gir h\u00e5p for bedre og mer n\u00f8yaktig behandling av kreftpasienter. Man kan ogs\u00e5 hindre un\u00f8dvendig behandling og plagene denne gir.<\/strong><\/p>\n<p>I 2011 definerte den Nasjonale SamarbeidsGruppen (NSG) for medisinsk og helsefaglig forksning et felles satsingsomr\u00e5de for kreftforskning,<\/p>\n<div class=\"page\" title=\"Page 1\">\n<div class=\"layoutArea\">\n<div class=\"column\">\n<p><a href=\"https:\/\/kreftgenomikk.w.uib.no\/files\/2018\/05\/NSG-satsingsomr\u00e5de-kreft-beskrivelse-apr11-final.pdf\" target=\"_blank\" rel=\"noopener\">Nasjonalt satsingsomr\u00e5de kreft: \u00a0Individuell kreftbehandling basert p\u00e5 genprofilen av egen svulst<\/a><\/p>\n<p>Dette la grunnlaget for en egen utlysning fra Forskningsr\u00e5det som ga starten for v\u00e5rt konsortium.<\/p>\n<\/div>\n<\/div>\n<\/div>\n<p>[\/et_pb_text][\/et_pb_column][et_pb_column type=&raquo;1_3&#8243;][et_pb_sidebar admin_label=&raquo;Nyhetsarkiv og konferanser&raquo; orientation=&raquo;left&raquo; area=&raquo;primary&raquo; background_layout=&raquo;light&raquo; remove_border=&raquo;off&raquo;]<\/p>\n<p>&nbsp;<\/p>\n<p>[\/et_pb_sidebar][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>","protected":false},"excerpt":{"rendered":"<p>[et_pb_section admin_label=&raquo;Seksjon&raquo; fullwidth=&raquo;on&raquo; specialty=&raquo;off&raquo;][et_pb_fullwidth_post_title admin_label=&raquo;Fullbreddes innleggstittel&raquo; title=&raquo;on&raquo; meta=&raquo;off&raquo; author=&raquo;on&raquo; date=&raquo;on&raquo;&#46;&#46;&#46;<\/p>\n","protected":false},"author":4078,"featured_media":2891,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[175359],"tags":[],"class_list":["post-4528","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-forside-7"],"_links":{"self":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/posts\/4528","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/users\/4078"}],"replies":[{"embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/comments?post=4528"}],"version-history":[{"count":7,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/posts\/4528\/revisions"}],"predecessor-version":[{"id":5553,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/posts\/4528\/revisions\/5553"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/media\/2891"}],"wp:attachment":[{"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/media?parent=4528"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/categories?post=4528"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kreftgenomikk.w.uib.no\/no\/wp-json\/wp\/v2\/tags?post=4528"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}